Tech Company Financing Transactions
AltPep Funding Round
AltPep, based in Mercer Island, received $53 million from Senator Investment Group, Alexandria Venture Investments and Eli Lilly and Company.
Transaction Overview
Company Name
Announced On
6/26/2023
Transaction Type
Venture Equity
Amount
$53,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to accelerate its SOBIN therapeutics into Phase 1 clinical trials for both Alzheimer's and Parkinson's diseases. Funds will also be used to advance AltPep's first SOBA� diagnostic, which has FDA Breakthrough Designation, toward FDA clearance.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
7683 SE 27th St. 462
Mercer Island, WA 98040
USA
Mercer Island, WA 98040
USA
Phone
Undisclosed
Website
Email Address
Overview
AltPep spun out from the Daggett Research Group lab at the University of Washington, and AltPep's technology is based on decades of research and discoveries from the lab, culminating in technology that targets a fundamental toxic protein structure formed during amyloidogenesis.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Valerie Daggett
Chief Financial Officer
Charles Horne
Chief Operating Officer
Patrik Edenholm
VP - Bus. Development
Kurt Becker
Browse more venture capital transactions:
Prev: 6/26/2023: Myra Vision venture capital transaction
Next: 6/26/2023: BentoML venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records on this site are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs